`
`From:
`Sent:
`To:
`Cc:
`Subject:
`
`Justin Nemunaitis
`Monday, September 19, 2016 6:31 PM
`Leslie V. Payne; Chris First; Douglas Wilson
`rapid@caldwellcc.com
`RE: RC WFD Motion for Stay
`
`Les,
`
` I
`
` understand from our call today that Weatherford will not be responding to the requests in my email below nor
`agreeing to move up the deadline for the RFAs I served on Friday so that we have responses before our response to the
`motion to stay is due. Please let me know if I have that wrong.
`
`Regards,
`Justin
`
`From: Justin Nemunaitis
`Sent: Friday, September 16, 2016 4:56 PM
`To: Leslie V. Payne <lpayne@hpcllp.com>; Chris First <cfirst@hpcllp.com>; Douglas Wilson <dwilson@hpcllp.com>
`Cc: rapid@caldwellcc.com
`Subject: RE: RC WFD Motion for Stay
`
`Please see the attached formalization of the RFAs in my email below.
`
`From: Justin Nemunaitis
`Sent: Friday, September 16, 2016 11:01 AM
`To: Leslie V. Payne <lpayne@hpcllp.com>; 'Chris First' <cfirst@hpcllp.com>; Douglas Wilson <dwilson@hpcllp.com>
`Cc: rapid@caldwellcc.com
`Subject: RC WFD Motion for Stay
`
`Les and Chris,
`
`In addressing whether a stay would prejudice Rapid Completions, Weatherford’s motion contains the following factual
`assertion:
`
`
`Since the very beginning of this case, Defendants have operated independently with regard to IPRs.
`Weatherford decided to file its IPRs when it did on a completely independent basis, with no consultation or
`agreement – explicit or implicit – with Baker Hughes or Peak.
`
`
`There is no support cited for this assertion, but we would like some information to test what you mean. Because of the
`short turn around on our response brief, please let me know if you admit or deny the following statements by COB on
`Monday (our response is due on Tuesday I believe). The terms “Weatherford” and “Baker Hughes” include employees,
`in‐house counsel, and outside counsel for those Defendant entities. The term “discussed” includes in‐person and over
`the phone discussions, as well as written correspondence such as through email.
`
`
`1. Before Weatherford filed its IPRs against the patents‐in‐suit, Weatherford discussed with Baker Hughes that it
`might file its own IPRs against one or more of the patents‐in‐suit.
`
`1
`
`1 of 2
`
`Exhibit 2037
`IPR2016-01517
`
`
`
`2. Before Weatherford filed its IPRs against the patents‐in‐suit, Weatherford and Baker Hughes discussed which
`references would be included in Weatherford's IPRs.
`3. Before Weatherford filed its IPRs against the patents‐in‐suit, Baker Hughes suggested to Weatherford that it
`should include one or more of the invalidity theories contained Weatherford's IPRs.
`4. With regard to at least one IPR filed by Baker Hughes against a patent‐in‐suit, Weatherford and Baker Hughes
`discussed which references would be included in that IPR.
`5. With regard to at least one IPR filed by Baker Hughes against a patent‐in‐suit, Weatherford suggested to Baker
`Hughes that it should include one or more of the invalidity theories contained in that IPR.
`6. Weatherford did not decide to file its own IPRs against the patents‐in‐suit until after it discussed that idea with
`Baker Hughes.
`
`These are fairly high level statements, but let me know if you believe your responses would be privileged. Also, as a
`procedural matter, we can treat these as RFAs, but as I said, we will need an agreement from you to provide responses
`by Monday COB.
`
`Regards,
`Justin
`
`
`Justin Nemunaitis ||| Caldwell Cassady & Curry
`2101 Cedar Springs Road, Suite 1000, Dallas, TX 75201
`Direct Line: 214.888.4853
`Main Line Telephone:214.888.4848
`Fax Line: 214.888.4849
`
`
`NOTICE OF CONFIDENTIALITY:
`The information contained in this e-mail may be subject to the ATTORNEY-CLIENT and ATTORNEY WORK
`PRODUCT PRIVILEGE and be CONFIDENTIAL. It is intended only for the recipient(s) designated
`above. Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may
`be unlawful. If you have received this communication in error, please notify Caldwell Cassady & Curry P.C. immediately.
`
`
`2
`
`2 of 2
`
`Exhibit 2037
`IPR2016-01517